Effect of fish oil supplementation for two generations on changes of lymphocyte function induced by walker 256 cancer cachexia in rats

Nutrition and Cancer

Volumn 61, Issue 5, 2009, Pages 670-679

  Folador, Alessandra ^a   De Lima Salgado, Thais Martins ^a   Hirabara, Sandro Massao ^b   Aikawa, Julia ^c   Yamazaki, Ricardo K ^c   Martins, Edgair F ^a   De Oliveira, Heloisa Helena P ^c   Pizatto, Nathalia ^c   Kanunfre, Carla C ^a   Peres, Carmem M ^a   Fernandes, Luiz C ^c   Curi, Rui ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSIDADE CRUZEIRO DO SUL   (Brazil)

^c FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

FISH OIL; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CACHEXIA; CD4 CD8 RATIO; CELL ISOLATION; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; EX VIVO STUDY; FEMALE; LYMPHOCYTE FUNCTION; LYMPHOCYTE MEMBRANE; LYMPHOCYTE PROLIFERATION; MESENTERY LYMPH NODE; NONHUMAN; PROTEIN BLOOD LEVEL; RAT; SPLEEN; STIMULATION; SUPPLEMENTATION; THYMUS; TUMOR GROWTH; WALKER CARCINOMA;

ANIMALS; ANTICARCINOGENIC AGENTS; CACHEXIA; CARCINOMA 256, WALKER; CELL MEMBRANE; CELL PROLIFERATION; CELL SURVIVAL; CYTOKINES; FEMALE; FISH OILS; LYMPH NODES; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MALE; NEOPLASM TRANSPLANTATION; RATS; RATS, WISTAR; SPLEEN; THYMUS GLAND; WEIGHT LOSS;

ANIMALIA; RATTUS;

EID: 70449633171     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635580902825548     Document Type: Article

References (45)

1. Nelson KA, Walsh D, and Sheehan FA: The cancer anorexia-cachexia syndrome. J Clin Oncol 12, 213-225, 1994.
2. Rivoltini L, Carrabba M, Huber V, Castelli C, Novellino L, et al.: Immunity to cancer: Attack and escape in T lymphocyte-tumor cell interaction. Immunol Rev 188, 97-113, 2002.
3. Dunn GP, Bruce AT, Ikeda H, Old LJ, and Schreiber RD: Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol 3, 991-998, 2002.
4. Armstrong TD, Pulaski BA, and Ostrand-Rosenberg S: Tumor antigen presentation: changing the rules. Cancer Immunol Immunother 46, 70-74, 1998.
5. Das PK, Van den Wijngaard RM,Wankowicz-Kalinska A, and Le Poole IC: A symbiotic concept of autoimmunity and tumor immunity: lessons from vitiligo. Trends Immunol 22, 130-136, 2001.
6. Bonnotte B, Favre N, Moutet M, Fromentin A, Solary E, et al.: Role of tumor cell apoptosis in tumor antigen migration to the draining lymph nodes. J Immunol 164, 1995-2000, 2000.
7. Torre-Amione G, Beauchamp RD, Koeppen H, Park BH, Schreiber H, et al.: A highly immunogenic tumor transfected with a murine transforming growth factor type beta 1 cDNA escapes immune surveillance. Proc Natl Acad Sci USA 87, 1486-1490, 1990.
8. Onrust SV, Hartl PM, Rosen SD, and Hanahan D: Modulation of L-selectin ligand expression during an immune response accompanying tumorigenesis in transgenic mice. J Clin Invest 97, 54-64, 1996.
9. Chen L, Linsley PS, and Hellstrom KE: Costimulation of T cells for tumor immunity. Immunol Today 14, 483-486, 1993.
10. Das UN: Beneficial effect(s) of n-3 fatty acids in cardiovascular diseases: but, why and how? Prostaglandins Leukot Essent Fatty Acids 63, 351-362; 2000.
11. Sun D, Krishnan A, Zaman K, Lawrence R, Bhattacharya A, et al.: Dietary n-3 fatty acids decrease osteoclastogenesis and loss of bone mass in ovariectomized mice. J Bone Miner Res 18, 1206-1216, 2003.
12. Connor WE, DeFrancesco CA, and Connor SL: N-3 fatty acids from fish oil: effects on plasma lipoproteins and hypertriglyceridemic patients. Ann NY Acad Sci 683, 16-34, 1993.
13. Meydani SN, Lichtenstein AH, Cornwall S, Meydani M, Goldin BR, et al. Immunological effects of National Cholesterol Education Panel Step-2 diets with and without fish-derived n-3 fatty acid enrichment. J Clin Invest 92, 105-113, 1993.
14. Tashiro T,YamamoriH, TakagiK,Hayashi N, Furukawa K, et al.: n-3 versus n-6 polyunsaturated fatty acids in critical illness. Nutrition 14, 551-553, 1998.
15. Tisdale MJ: Loss of skeletal muscle in cancer: biochemical mechanisms. Front Biosci 6, D164-D174, 2001.
16. Wigmore SJ, Barber MD, Ross JA, Tisdale MJ, and Fearon KC: Effect of oral eicosapentaenoic acid on weight loss in patients with pancreatic cancer. Nutr Cancer 36, 177-184, 2000.
17. Barber MD, Ross JA, Voss AC, Tisdale MJ, and Fearon KC: The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer. Br J Cancer 81, 80-86, 1999.
18. Fearon KC, Von Meyenfeldt MF, Moses AG, Van Geenen R, Roy A, et al.: Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: A randomized double blind trial. Gut 52, 1479-1486, 2003.
19. Folador A, Hirabara SM, Bonatto SJ, Aikawa J, Yamazaki RK, et al.: Effect of fish oil supplementation for 2 generations on changes in macrophage function induced by Walker 256 cancer cachexia in rats. Int J Cancer 120, 344-350, 2007.
20. Lewis RS: Calcium signaling mechanisms in T lymphocytes. Annu Rev Immunol 19, 497-521, 2001.
21. Dabbagh K and Lewis DB: Toll-like receptors and T-helper-1/T-helper-2 responses. Curr Opin Infect Dis 16, 199-204, 2003.
22. Ohl L, Bernhardt G, Pabst O, and Förster R: Chemokines as organizers of primary and secondary lymphoid organs. Semin Immunol 15, 249-255, 2003.
23. Alexander NJ and Smythe NL: Dietary fat modulation of in vitro lymphocyte function. Ann Nutr Metab 32, 192-199, 1988.
24. Peterson LD, Jeffery NM, Thies F, Sanderson P, Newsholme EA, et al.: Eicosapentaenoic and docosahexaenoic acids alter rat spleen leukocyte fatty acid composition and prostaglandin E2 production but have different effects on lymphocyte functions and cell-mediated immunity. Lipids 33, 171-180, 1998.
25. Thies F, Nebe-von-Caron G, Powell JR, Yaqoob P, Newsholme EA, et al.: Dietary supplementation with gamma-linolenic acid or fish oil decreases T lymphocyte proliferation in healthy older humans. J Nutr 131, 1918-1927, 2001.
26. Jolly CA,McMurray DN, and Chapkin RS: Effect of dietary n-3 fatty acids on interleukin-2 and interleukin-2 receptor alpha expression in activated murine lymphocytes. Prostaglandins Leukot Essent Fatty Acids 58, 289-293, 1998.
27. Wallace FA, Miles EA, EVans C, Stock TE, Yaqoob P, et al.: Dietary fatty acids influence the production of Th1- but not Th2-type cytokines. J Leukoc Biol 69, 449-457, 2001.
28. Yaqoob P, Newsholme EA, and Calder PC: The effect of dietary lipid manipulation on rat lymphocyte subsets and proliferation. Immunology 82, 603-610, 1994.
29. Thies F, Nebe-von-Caron G, Powell JR, Yaqoob P, Newsholme EA, et al.: Dietary supplementation with eicosapentaenoic acid, but not with other long-chain n-3 or n-6 polyunsaturated fatty acids, decreases natural killer cell activity in healthy subjects aged >55 y. Am J Clin Nutr 73, 539-548, 2001.
30. Nishiyama-Naruke A, Sousa JAA, Carnelos Filho M, and Curi R: HPLC determination of underivatized fatty acid saponified at low temperature analysis of fatty acids in oils and tissues. Analyt Lett 31, 2565-2576, 1998.
31. Stewart HL, Snell KC, Dunham LJ, and Schlyen SM: Atlas of Tumor Pathology, Section XII. Washington, DC: Air Force Institute of Pathology, pp. 216-271, 1959.
32. Togni V, Ota CC, Folador A, J́unior OT, Aikawa J, et al.: Cancer cachexia and tumor growth reduction inWalker 256 tumor-bearing rats supplemented with N-3 polyunsaturated fatty acids for one generation. Nutr Cancer 46, 52-58, 2003.
33. Lima TM, Lima MM, Almeida DC, Mendonça JR, and Curi R: Cachexia induced by Walker 256 tumor growth causes rat lymphocyte death. Cancer Immunol Immunother 54, 179-186, 2005.
34. Abbas AK and Lichtaman AH: Cellular and Molecular Immunology, 6th ed. New York: Elsevier, 2006.
35. Kelley DS, Taylor PC, Nelson GJ, and Mackey BE: Dietary docosahexaenoic acid and immunocompetence in young healthy men. Lipids 33, 559-566, 1998.
36. Purasiri P, Mckechnie A, Heys SD, and Eremin O: Modulation in vitro of human natural cytotoxicity, lymphocyte proliferative response to mitogens and cytokine production by essential fatty acids. Immunology 92, 166-172, 1997.
37. Argiĺes JM and Ĺopez-Soriano FJ: The role of cytokines in cancer cachexia. Med Res Rev 19, 223-248, 1999.
38. Moldawer LL, Gelin J, Scherst́en T, and Lundholm KG: Circulating interleukin-1 and tumor necrosis factor during inflammation. Am J Physiol 253, R922-R928, 1987.
39. Costelli P, Carb́o N, Tessitore L, Bagby GJ, Lopez-Soriano FJ, et al.: Tumor necrosis factor-alpha mediates changes in tissue protein turnover in a rat cancer cachexia model. J Clin Invest 92, 2783-2789, 1993.
40. Stovroff MC, Fraker DL, Swedenborg JA, and Norton JA: Cachectin/tumor necrosis factor: A possible mediator of cancer anorexia in the rat. Cancer Res 48, 4567-4572, 1988.
41. Matthys P, Dijkmans R, Proost P, Van Damme J, Heremans H, et al.: Severe cachexia in mice inoculated with interferon-gamma-producing tumor cells. Int J Cancer 49, 77-82, 1991.
42. Matthys P, Heremans H, Opdenakker G, and Billiau A: Anti-interferongamma antibody treatment, growth of Lewis lung tumours in mice and tumour-associated cachexia. Eur J Cancer 27, 182-187, 1991.
43. Howell WM and Rose-Zerilli MJ: Interleukin-10 polymorphisms, cancer susceptibility, and prognosis. Fam Cancer 5, 143-149, 2006.
44. Taylor DD, Gercel-Taylor C, Jenis LG, andDevereux DF: Identification of a human tumor-derived lipolysis-promoting factor. Cancer Res 52, 829-834, 1992.
45. Todorov P, Cariuk P, McDevitt T, Coles B, Fearon K, et al.: Characterization of a cancer cachectic factor. Nature 379, 739-742, 1996.